Arch Biopartners Completes Enrollment in Phase II Trial of Metablok (LSALT Peptide) in Hospitalized Patients with COVID-19
May 04, 2021 07:00 ET
|
Arch Biopartners
TORONTO, May 04, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
Global Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR of 10.40% during the forecast period - By PMI
April 30, 2021 10:05 ET
|
PMI
Covina, CA, April 30, 2021 (GLOBE NEWSWIRE) -- The Global Thalassemia Treatment Market accounted for US$ 2.3 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to...
Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy
April 07, 2021 08:00 ET
|
Immutep Limited
Sydney, AUSTRALIA, April 07, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for...
Appointment of Ben Vertannes as Head of Global Marketing
March 08, 2021 02:00 ET
|
Ascension
PRESS RELEASE Appointment of Ben Vertannes as Head of Global Marketing LONDON, March 8, 2021 – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage pharmaceutical company...
Global Diabetes Drugs Market–Analysis and Demand with Forecast Overview to 2029 - by PMI
January 12, 2021 10:05 ET
|
PMI
Covina, CA, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The significant growth in the market can be attributed to factors, such as the rising prevalence of diabetes and the increasing number of programs...
Arch Biopartners Closes Non-Brokered Private Placement
December 29, 2020 08:33 ET
|
Arch Biopartners
TORONTO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
Immutep Announces Australian Patent Grant For IMP701 Antibody
November 09, 2020 08:00 ET
|
Immutep Limited
Sydney, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces the grant of patent no. 2015229103 entitled “Antibody molecules...
McEldrew Young Partner Eric L. Young Named “Lawyer of the Year” for 2020 by the Taxpayers Against Fraud Education Fund
November 02, 2020 11:18 ET
|
McEldrew Young Law
PHILADELPHIA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- The law firm of McEldrew Young Purtell Merritt is pleased to announce that its co-founder and name partner, Eric L. Young, was honored as one of two...
BioNTech übernimmt GMP-Produktionsstätte zur Ausweitung der COVID-19 Impfstoffproduktionskapazitäten im ersten Halbjahr 2021
September 17, 2020 04:00 ET
|
BioNTech SE
Mainz, Deutschland, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Anlage wird eine der größten mRNA-Produktionsstätten in Europa und ist das dritte Werk im Produktionsnetzwerk von BioNTech in...
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
September 17, 2020 04:00 ET
|
BioNTech SE
Mainz, Germany, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Facility will become one of the largest mRNA manufacturing sites in Europe and the third site in the BioNTech manufacturing network in...